EnBio Holdings, Inc (TYO:6092)
Japan
· Delayed Price · Currency is JPY 730.00
+39.00 (5.64%)
Mar 10, 2026, 3:30 PM JST
EnBio Holdings Revenue
EnBio Holdings had revenue of 3.42B JPY in the quarter ending December 31, 2025, with 53.14% growth. This brings the company's revenue in the last twelve months to 11.58B, up 7.41% year-over-year. In the fiscal year ending March 31, 2025, EnBio Holdings had annual revenue of 10.67B with 11.42% growth.
Revenue (ttm)
11.58B
Revenue Growth
+7.41%
P/S Ratio
0.51
Revenue / Employee
114.64M
Employees
101
Market Cap
5.93B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 10.67B | 1.09B | 11.42% |
| Mar 31, 2024 | 9.58B | 1.46B | 17.92% |
| Mar 31, 2023 | 8.12B | -867.00M | -9.65% |
| Mar 31, 2022 | 8.99B | 2.15B | 31.39% |
| Mar 31, 2021 | 6.84B | -568.00M | -7.67% |
| Mar 31, 2020 | Pro | Pro | Pro |
| Mar 31, 2019 | Pro | Pro | Pro |
| Mar 31, 2018 | Pro | Pro | Pro |
| Mar 31, 2017 | Pro | Pro | Pro |
| Mar 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Sun Messe | 16.58B |
| Mitsumura Printing | 14.20B |
| Sanko Sangyo | 10.35B |
| System Location | 1.71B |
| CRESTEC | 18.18B |
| Maruhachi Warehouse Company | 4.93B |
| Honyaku Center | 11.01B |
| Frontier Management | 13.49B |